Suppr超能文献

肾上皮细胞膜中拮抗剂占据的V2血管加压素受体的侧向移动性。

Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells.

作者信息

Pavo I, Jans D A, Peters R, Penke B, Fahrenholz F

机构信息

Max Planck Institut für Biophysik, Frankfurt, Germany.

出版信息

Biochim Biophys Acta. 1994 Sep 8;1223(2):240-6. doi: 10.1016/0167-4889(94)90232-1.

Abstract

The lateral mobility of membrane integral receptors has been implicated as playing a significant role in signal transduction. The adenylate cyclase-coupled vasopressin V2 receptor has been shown to be highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature using a fluorescent vasopressin agonist, with lateral mobility of the V2 receptor proposed to play a role in both adenylate cyclase activation and ligand induced receptor internalization and down-regulation. This study reports the synthesis and characterization of two new fluorescent antagonists [(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)1,D-Tyr2,Ile4,Lys9(N6-fluoresceinylaminothiocarbonyl )]AVP (FL-AVP-anta) and [(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)1,D-Tyr2,Ile4,Lys9(N6-tetramethylrhodamylaminothioca rbonyl)]AVP (TR-AVP-anta) for the V2 receptor. The latter was used to determine the parameters of lateral mobility of the V2 receptor in the non-activated antagonist-occupied form. Using fluorescence photobleaching techniques, results were largely comparable to those for agonist-occupied receptor, indicating high mobility at 37 degrees C. Antagonistic properties of the V2 receptor ligands are apparently not related to decreased receptor lateral mobility. Photobleaching measurements, however, did show that in contrast to V2 agonist, V2 antagonist did not induce receptor immobilization due to aggregation with time at 37 degrees C, indicating that this could be of mechanistic importance in the internalization process.

摘要

膜整合受体的侧向迁移被认为在信号转导中起重要作用。使用荧光血管加压素激动剂已表明,在生理温度下,腺苷酸环化酶偶联的血管加压素V2受体在LLC-PK1肾上皮细胞膜中具有高度的侧向迁移性,V2受体的侧向迁移被认为在腺苷酸环化酶激活以及配体诱导的受体内化和下调中均发挥作用。本研究报道了两种新型荧光拮抗剂[(β-巯基-β,β-环亚戊基丙酸)1,D-酪氨酸2,异亮氨酸4,赖氨酸9(N⁶-荧光素基氨基硫羰基)]血管加压素(FL-AVP-anta)和[(β-巯基-β,β-环亚戊基丙酸)1,D-酪氨酸2,异亮氨酸4,赖氨酸9(N⁶-四甲基罗丹明基氨基硫羰基)]血管加压素(TR-AVP-anta)的合成与表征,用于V2受体。后者用于确定未激活的拮抗剂占据形式下V2受体的侧向迁移参数。使用荧光漂白技术,结果与激动剂占据受体的结果基本相当,表明在37℃时具有高迁移率。V2受体配体的拮抗特性显然与受体侧向迁移率降低无关。然而,漂白测量确实表明,与V2激动剂相反,V2拮抗剂在37℃下不会因随时间聚集而诱导受体固定,这表明这可能在内在化过程中具有重要的机制意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验